evotec ag (EVT:Xetra)
Peter Machin Ph.D., FRSC, FMedSci
Former Member of Scientific Advisory Board, Evotec AG
|Age||Total Calculated Compensation||This person is connected to 25 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Dr. Peter Machin, Ph.D., FRSC, FMedSci works as an Independent Drug Discovery Consultant with a medicinal chemistry background. Dr. Machin has more than thirty years experience of drug discovery and development in major pharmaceutical companies. He has held a number of senior positions; at Roche as Head of Chemistry in the UK, then at SmithKline Beecham as Vice President of Discovery Chemistry Europe and most recently, as Global Senior Vice President of Discovery Research ...
Manfred Eigen CampusPhone: 49 4056 0810
Hamburg, Hamburg 22419
Fax: 49 405 608 1222
Board Members Memberships*There is no Board Members Memberships data available.
Imperial College Business School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|James A. Bianco M.D.||Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee|
CTI BioPharma Corp.
|Robert I. Blum||Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern|
|Michael M. Morrissey Ph.D.||Chief Executive Officer, President and Director|
|Adelene Q. Perkins||Chairman of The Board, Chief Executive Officer and President|
Infinity Pharmaceuticals, Inc.
|$552.0K||Compensation as of Fiscal Year 2013.|